Qi Cheng

Also affiliated with Zhejiang Cancer Hospital, Nanjing Drum Tower Hospital, Wuxi People's Hospital, Pharmaceutical Biotechnology (Czechia), State Key Laboratory of Pharmaceutical Biotechnology, Inner Mongolia Medical University, Nanjing Medical University, Nanjing University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “In Situ Pre-Treatment of Vascularized Composite Allografts With a Targeted Complement Inhibitor Protects Against Brain Death and Ischemia Reperfusion Induced Injuries”.

In Situ Pre-Treatment of Vascularized Composite Allografts With a Targeted Complement Inhibitor Protects Against Brain Death and Ischemia Reperfusion Induced Injuries

Frontiers in Immunology(2021)10.3389/fimmu.2021.630581

N/A

0DataRank · unranked

7 citations

M. Mahdi Sleiman, Qi Cheng, Zhenxiao Tu, Peng Zhu, Martin Goddard +6 more